Therapeutic Strategy for Parkinson's Disease: Targeting Zinc-Binding Protein in Astrocytes

Proceedings for Annual Meeting of The Japanese Pharmacological Society
doi 10.1254/jpssuppl.93.0_1-s17-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Pharmacological Society

Related search

Targeting Aged Astrocytes May Be a New Therapeutic Strategy in Parkinson's Disease

Movement Disorders
Neurology
2018English

Therapeutic Directions for Parkinson's Disease

Movement Disorders
Neurology
2010English

A Novel Protein Therapeutic Joint Retention Strategy Based on Collagen-Binding Avimers

Journal of Orthopaedic Research
OrthopedicsSports Medicine
2017English

Therapeutic Approach Targeting Apolipoprotein E Binding Region and Low-Density Lipoprotein Receptor for Alzheimer’s Disease

Neuroimmunology and Neuroinflammation
NeurologyImmunology
2018English

A New Therapeutic Strategy for Malaria: Targeting T Cell Exhaustion

Nature Immunology
AllergyImmunology
2012English

A Therapeutic Maneuver for Oropharyngeal Dysphagia in Patients With Parkinson's Disease

Clinics
Medicine
2008English

Targeting Tau Protein Stability in Alzheimer Disease to Identify Novel Therapeutic Entry Points

Journal of the Neurological Sciences
Neurology
2015English

The Charcot Marie Tooth Disease Protein LITAF Is a Zinc-Binding Monotopic Membrane Protein

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2016English

Targeting Tankyrase 1 as a Therapeutic Strategy for BRCA-associated Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy